Last reviewed · How we verify

NCT02322996

Phenotyping Acute Pain for Discovery Research and Directed Therapeutics

Withdrawn Last updated 23 February 2018
What this trial tests

trial testing questionnaires in Post op Pain. Withdrawn.

Timeline
21 February 2018
Primary endpoint
21 February 2018
21 February 2018

Quick facts

Lead sponsorEast Carolina University
StatusWithdrawn
Study typeOBSERVATIONAL
Start date21 February 2018
Primary completion21 February 2018
Estimated completion21 February 2018
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

East Carolina University

Who can join

18 and older, any sex, with Post op Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of the current study is to combine existing and new tools for quantifying patient self-report to characterize changes in acute pain. The ability to quantitatively measure self-report provides behavioral pain phenotypes that can serve as the basis for clustering patients into sub-groups based on their self-report of their symptoms, eliminating observer based perceptions of patients' pain.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of questionnaires

Trials testing the same drug.

Other East Carolina University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02322996.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing